Document is current
Any future updates will be listed below
-
Authors
Martínez-de-la-Casa, José María
Parrilla-Vallejo, María
Rodríguez-Aguilar, Laura
Rodríguez-González, Virginia
Jacobs, Thomas
Carratalá-Beltrán, Joaquín María
-
Funding
Funding for this research was provided by:
Glaukos Medical Spain S.L. (NA)
- License Information
-
More Information
Article History
Received: 28 February 2026
Accepted: 24 May 2026
First Online: 2 June 2026
Declarations
:
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.JMC: Grants: Santen, Ivantis, Abbvie, Viatris, Glaukos, Thea, Omikron, Nova Eye Medical, Vialase. Consultant: Abbvie, Santen, Alcon, Viatris, Novartis, Thea, B&L, Glaukos, AJL, Visufarma, Angelini. Speaker: Abbvie, Santen, Alcon, Viatris, Novartis, Thea, B&L, Glaukos, iCare, Angelini, Nova Eye Medical.The rest of the authors do not have any conflict to declare.
: The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
